← back to search

C. Oliver Hanemann

University of Alabama at Birmingham · US
🔎 Find collaborators in Neurology · Epidemiology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Neurology · Epidemiology
Research interest
Research interests include Medicine, Meningioma, Neurofibromatosis, Neurofibromatoses, Amyotrophic lateral sclerosis, and Medical physics.
h-index
citations
2,700
works
25
NIH funding
primary concept
email

Recent publications

A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification
Nature Genetics 2026cited by 3position: middledoi
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium
Neuro-Oncology 2025cited by 3position: middledoi
Transforming molecular neuropathology for adult brain tumor patients in the UK: Insights on implementation, adoption, and patient access (2021-2024)
Neuro-Oncology Practice 2025cited by 2position: middledoi
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma
Neuro-Oncology 2025cited by 1position: middledoi
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Neuro-Oncology 2024cited by 121position: middledoi
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Nature Medicine 2024cited by 63position: middledoi
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
Genetics in Medicine 2022cited by 268position: middledoi
BIOM-56. MIR-497 AND 219 IN BLOOD AID MENINGIOMA CLASSIFICATIONMIR-497 AND 219 IN BLOOD AID MENINGIOMA CLASSIFICATION
Neuro-Oncology 2022cited by 0position: firstdoi
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
Genetics in Medicine 2021cited by 744position: middledoi
Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas
International Journal of Molecular Sciences 2021cited by 26position: lastdoi
Integrated phospho-proteogenomic and single-cell transcriptomic analysis of meningiomas establishes robust subtyping and reveals subtype-specific immune invasion
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 10position: middledoi
HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis
Journal of Clinical Investigation 2020cited by 57position: middledoi
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
Neuro-Oncology 2019cited by 271position: middledoi
The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2019cited by 37position: middledoi
Utilization of volumetric magnetic resonance imaging for baseline and surveillance imaging in Neuro-oncology
British Journal of Radiology 2019cited by 9position: middledoi
Advances in multidisciplinary therapy for meningiomas
Neuro-Oncology 2018cited by 164position: middledoi
Molecular and translational advances in meningiomas
Neuro-Oncology 2018cited by 140position: middledoi
Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials
Neurology 2016cited by 46position: middledoi
A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2016cited by 45position: middledoi
Current status and recommendations for biomarkers and biobanking in neurofibromatosis
Neurology 2016cited by 22position: firstdoi
Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DCAF1-Mediated Inhibition of the Hippo Pathway Kinases Lats1 and 2 in the Nucleus
Cancer Cell 2014cited by 263position: middledoi
Recent developments in neurofibromatoses and RASopathies: Management, diagnosis and current and future therapeutic avenues
American Journal of Medical Genetics Part A 2014cited by 56position: middledoi
CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies
American Journal of Medical Genetics Part A 2014cited by 27position: middledoi
Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria
American Journal of Medical Genetics Part A 2013cited by 185position: middledoi
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
The Lancet Neurology 2013cited by 137position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael D. Jenkinson · Collaborative Group (United States)3 papers (2019–2025)Christopher McDermott · Lancashire Teaching Hospitals NHS Foundation Trust2 papers (2016–2019)Timothy Harrower · University of Exeter2 papers (2016–2019)Nancy Ratner · International Society for Experimental Hematology2 papers (2013–2014)Siddharthan Chandran · Edinburgh Royal Infirmary2 papers (2016–2019)Felix Sahm · Heidelberg (Poland)2 papers (2021–2022)Timothy L. Williams · Johns Hopkins Medicine2 papers (2016–2019)Kathreena M. Kurian · University of Bristol2 papers (2021–2025)D. Gareth Evans · Translational Research Institute2 papers (2013–2014)Carolyn Young · University of Liverpool2 papers (2016–2019)Joanne Lewis · European Molecular Biology Laboratory2 papers (2019–2025) · 2 papers (2016–2019)Kevin Talbot · University of California, San Francisco2 papers (2016–2019) · 2 papers (2021–2022)Ammar Al‐Chalabi · Cambridge University Hospitals NHS Foundation Trust2 papers (2016–2019)Marc Ladanyi · Center for Cancer Research1 papers (2014–2014)Rosalie E. Ferner · Guy's and St Thomas' NHS Foundation Trust1 papers (2014–2014) · 1 papers (2019–2019)Marco Giovannini · The University of Texas Southwestern Medical Center1 papers (2013–2013)Jaishri O. Blakeley · Dana-Farber Cancer Institute1 papers (2013–2013)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Neurology · Epidemiology →